Edison Scientific announces agreement to deploy Kosmos across Pfizer R&D

Edison says its AI scientist will access Pfizer’s internal data to support researchers and inform R&D decisions.

3 Sources, 1h ago, first seen 1h ago

TLDR

Edison Scientific announced an agreement to deploy its AI platform and Kosmos across Pfizer’s biopharmaceutical R&D pipeline. The company says Kosmos will use Pfizer’s data to develop world models and support research decisions. Edison scientists and engineers will work with Pfizer teams to integrate the system into their workflows.

Today's Rank

—

Not ranked yet

Combined views

—

3 Sources, first seen 1h ago